title: Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
abstract: Cefotaxime and ceftriaxone have proven to be effective in pyogenic infections of the central nervous system. Since in some bacterial central nervous system infections the blood-cerebrospinal fluid (CSF) barrier is either minimally impaired or recovers in the course of the illness, we studied the penetration of both antibiotics in the absence of inflamed meninges. Patients who had undergone external ventriculostomies for noninflammatory occlusive hydrocephalus received either cefotaxime (2 g/30 min) or ceftriaxone (2 g/30 min) to treat extracerebral infections. Serum and CSF were drawn repeatedly after the first dose. With ceftriaxone, they were also drawn after the last dose. The concentrations of cefotaxime, its metabolite desacetylcefotaxime, and ceftriaxone were determined by high-performance liquid chromatography with UV detection. Maximum concentrations of cefotaxime in CSF were reached 0.5 to 8 h (median = 3 h; n = 6) after the end of the infusion and ranged from 0.14 to 1.81 mg/liter (median = 0.44 mg/liter; n = 6). Maximum levels of ceftriaxone in CSF ranging from 0.18 to 1.04 mg/liter (median = 0.43 mg/liter; n = 5) were seen 1 to 16 h (median = 12 h; n = 5) after the infusion. The elimination half-life of cefotaxime in CSF was 5.0 to 26.9 h (median = 9.3 h; n = 5), and that of ceftriaxone was 15.7 to 18.4 h (median = 16.8 h; n = 3). It is concluded that after a single dose of 2 g, maximal concentrations of cefotaxime and ceftriaxone in CSF do not differ substantially. The long elimination half-lives guarantee uniform concentrations in CSF. These concentrations reliably inhibit highly susceptible bacteria but cannot be relied on to inhibit staphylococci and penicillin G-resistant Streptococcus pneumoniae.
authors.affiliation: Department of Neurology, University of Göttingen, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Nau
authors.forename: H W
authors.initials: HW
authors.lastname: Prange
authors.forename: P
authors.initials: P
authors.lastname: Muth
authors.forename: G
authors.initials: G
authors.lastname: Mahr
authors.forename: S
authors.initials: S
authors.lastname: Menck
authors.forename: H
authors.initials: H
authors.lastname: Kolenda
authors.forename: F
authors.initials: F
authors.lastname: Sörgel
mesh_terms: D000368:Aged; D001825:Body Fluid Compartments; D002439:Cefotaxime / Q000097:blood / Q000134:cerebrospinal fluid*; D002443:Ceftriaxone / Q000097:blood / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D008297:Male; D008578:Meninges / Q000737:chemistry* / Q000378:metabolism*; D008581:Meningitis / Q000378:metabolism*; D008875:Middle Aged; D008954:Models, Biological
chemical_list: D002443:Ceftriaxone; D002439:Cefotaxime